Navigation Links
22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire/ -- 22nd Century Group, Inc. (OTCBB: XXII) today announced that Joseph Pandolfino, Chief Executive Officer, and Henry Sicignano III, President, will present at RetailInvestorConferences.com.

DATE:

December 5, 2013

TIME:   

1:15 PM EST

LINK:  

www.retailinvestorconferences.com click on the red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

The Retail Investor Conferences event is part of the Virtual Investor Conference Series co-hosted by MUNCmedia, Better Investing (NAIC) and PR Newswire.  Individual investors, institutional investors, financial advisors and financial analysts are invited to attend.  

It is recommended that investors pre-register to save time and receive event updates.

About 22nd Century Group:

22nd Century Group, Inc. (OTCBB: XXII) is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. 22nd Century owns or is the exclusive licensee of 114 issued patents in 78 countries plus an additional 36 pending patent applications. Goodrich Tobacco Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century. Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. www.xxiicentury.com

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com is the world's largest monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites leading-edge online conferencing by PR Newswire with the investor communications capabilities of MUNCmedia's digital public relations, content marketing and audience development services and BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE 22nd Century Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
2. KaloBios to Present at BioCenturys NewsMakers in the Biotech Industry Conference
3. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
4. MEI Pharma to Present at BioCenturys NewsMakers in the Biotech Industry Conference
5. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
6. Dalia Dergham Joins Grace Century FZ LLC International Project Team
7. Grace Century Attends Provia Laboratories Cycle II Launch
8. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
11. Stanford scientists spark new interest in the century-old Edison battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):